In a groundbreaking revelation, Future Market Insights (FMI) has illuminated the extraordinary growth prospects of the Global Diabetic Retinopathy Industry. Projections indicate a remarkable Compound Annual Growth Rate (CAGR) of 5.8% from 2023 to 2033, propelling the market into a transformative journey. Valued at US$ 8.82 billion in 2023, the industry is set to soar, …